Jerome Ritz

63PUBLICATIONS

306CO-AUTHORS

Respiratory diseasesGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (63)

Sort by Publication Date:

|Jun 03, 2026

Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell Disease.

|May 27, 2026

Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

|Apr 30, 2026

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Apr 20, 2026

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

|Feb 04, 2026

Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.

Maria Vd Soares, Virginia Escamilla Gómez, Rita I Azevedo

|Nov 26, 2025

Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS.

Nurefsan E Sariipek, Ksenia R Safina, Wesley S Lu

Pageof 11

Frequent Collaborators

10 joint publications

Katie Maurer

Catherine J Wu

Kenneth J Livak

Livius Penter

Haesook T Kim

Corey S Cutler

Nicoletta Cieri

Donna S Neuberg

R Coleman Lindsley

Christopher J Gibson

Frequent Collaborators

10 joint publications

Katie Maurer

7 joint publications

Catherine J Wu

7 joint publications

Kenneth J Livak

7 joint publications

Livius Penter